boy in bed

CYSTARAN® Voucher
Program

boy in bed

CYSTARAN® Voucher
Program

boy in bed

CYSTARAN®
Voucher
Program

For Your Patients: A FREE Month’s Supply (4 Bottles) of CYSTARAN

To help patients access this offer, simply print and fill out the voucher below and send it with your patient’s CYSTARAN prescription to AllianceRx Walgreens Prime Specialty Pharmacy.* Their medication will be shipped directly to their home at no charge.

* Limit one offer per patient. No purchase is necessary. Offer valid in the United States and Puerto Rico, and void where prohibited by law. Not valid in the Commonwealth of Massachusetts. Subject to eligibility and terms and conditions, which are subject to change. Offer expires December 31, 2022.

cystaran voucher

For Your Patients: A FREE Month’s Supply (4 Bottles) of CYSTARAN

To help patients access this offer, simply print and fill out the voucher below and send it with your patient’s CYSTARAN prescription to AllianceRx Walgreens Prime Specialty Pharmacy.* Their medication will be shipped directly to their home at no charge.

* One-time use only. Not valid in MA.

Download Voucher

mobile phone icon

For assistance redeeming this offer, please call 1-877-534-9627.

For CYSTARAN prescription enrollment and ordering information click here.

plus icon

INDICATION & IMPORTANT SAFETY INFORMATION

CYSTARAN® (CYSTEAMINE OPHTHALMIC SOLUTION) 0.44% is a cystine-depleting agent indicated for the treatment of corneal cystine crystal accumulation in patients with cystinosis.

minus icon

INDICATION & IMPORTANT SAFETY INFORMATION

CYSTARAN® (CYSTEAMINE OPHTHALMIC SOLUTION) 0.44% is a cystine-depleting agent indicated for the treatment of corneal cystine crystal accumulation in patients with cystinosis.

IMPORTANT SAFETY INFORMATION

  • To minimize contaminating the dropper tip and solution, care should be taken not to touch the eyelids or surrounding areas with the dropper tip of the bottle. Keep bottle tightly closed when not in use.
  • There have been reports of benign intracranial hypertension (or pseudotumor cerebri) associated with oral cysteamine treatment that has resolved with the addition of diuretic therapy. There have also been reports associated with ophthalmic use of cysteamine; however, all of these patients were on concurrent oral cysteamine.
  • CYSTARAN contains benzalkonium chloride, which may be absorbed by soft contact lenses. Contact lenses should be removed prior to application of solution and may be reinserted 15 minutes following its administration.
  • CYSTARAN is for topical ophthalmic use only.
  • The most frequently reported ocular adverse reactions occurring in ≥ 10% of patients were sensitivity to light, redness, and eye pain/irritation, headache and visual field defects.

Please refer to CYSTARAN’s full Prescribing Information, available here.